Ceruloplasmin, superoxide dismutase and copper in autistic patients.
Tórsdóttir
Gudlaug
G
Institute of Pharmacy, Pharmacology and Toxicology, Department of Pharmacology and Toxicology, University of Iceland, Reykjavik, Iceland. gudlaugt@hi.is
Hreidarsson
Stefán
S
Kristinsson
Jakob
J
Snaedal
Jón
J
Jóhannesson
Torkell
T
D000328:Adult; D001321:Autistic Disorder / Q000453:epidemiology / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology; D002570:Ceruloplasmin / Q000737:chemistry / Q000378:metabolism*; D015331:Cohort Studies; D003300:Copper / Q000737:chemistry / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D013054:Spectrophotometry, Atomic / Q000379:methods; D013482:Superoxide Dismutase / Q000737:chemistry / Q000378:metabolism*
D003300:Copper; D013482:Superoxide Dismutase; D002570:Ceruloplasmin